VISION HEALTHCARE has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €122.56M and a net result of €-5.92M. Equity is growing by ~11.9% per year across the filed fiscal years. Its solvency ranks better than 60% of 85 sector peers (fiscal year 2024). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit advice for your own amount and term
Signals
Two signals. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-05-2025, 77 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
not confirmed
2024
77 d early
2023
23 d late
2022
21 d late
2021
60 d early
2020
45 d early
2019
67 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, full schema, statutory
Turnover
€11.99M▲ 4.8%
2023 · €11.43M
2018: €1.44M
2020: €6.88M
2021: €9.50M
2022: €11.24M
2023: €11.43M
2018 → 2024
EBIT margin
-9.5%▲ 4.8pp
2023 · -14.2%
2018: -41.0%
2020: -8.4%
2021: -10.5%
2022: -1.6%
2023: -14.2%
2018 → 2024
Net result
€-5.92M▼ 198%
2023 · €-1.99M
2018: €-375k
2020: €1.09M
2021: €-14.75M
2022: €1.43M
2023: €-1.99M
2018 → 2024
Working capital
€13.83M▼ 11.2%
2023 · €15.58M
2018: €2.13M
2020: €6.03M
2021: €7.88M
2022: €10.17M
2023: €15.58M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Turnover€6.88M-€9.50M▲ 38.1%€11.24M▲ 18.4%€11.43M▲ 1.7%€11.99M▲ 4.8%
Equity€85.36M-€120.04M▲ 40.6%€130.47M▲ 8.7%€128.48M▼ 1.5%€122.56M▼ 4.6%
Operating result€-576k-€-998k▼ 73.1%€-178k▲ 82.1%€-1.63M▼ 813%€-1.14M▲ 30.2%
Net result€1.09M-€-14.75M€1.43M€-1.99M€-5.92M▼ 198%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €1.14M in 2024 against €1.63M in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €253.86M
Fixed assets
€239.00M▼ 6.0%
Current assets
€14.86M▼ 7.9%
Equity and liabilities €253.86M
Equity
€122.56M▼ 4.6%
Debt
€131.30M▼ 7.4%
The debt ratio falls from 52.5% to 51.7%. Equity and debt are lower.
Key figures and ratios
Solvency
48.3%▲
2023 · 47.5%
ROE
-4.8%▼
2023 · -1.5%
ROA
-2.3%▼
2023 · -0.7%
Debt
€131.30M▼
2023 · €141.83M
Debt ≤ 1 year
€1.03M▲
2023 · €564k
Debt > 1 year
€128.41M▼
2023 · €136.95M
Income taxes
€30k▲
2023 · €25k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€270.31M€253.86M▼
Fixed assets21/28€254.17M€239.00M▼
Intangible fixed assets21-€65k
Financial fixed assets28€254.17M€238.93M▼
Affiliated companies280/1€254.17M€238.93M▼
Participating interests280€147.18M€147.18M=
Amounts receivable281€106.98M€91.75M▼
Current assets29/58€16.14M€14.86M▼
Amounts receivable within one year40/41€5.57M€4.82M▼
Trade receivables40€3.36M€2.76M▼
Other amounts receivable41€2.21M€2.07M▼
Current investments50/53€4.00M€9.90M▲
Other investments51/53€4.00M€9.90M▲
Cash at bank and in hand54/58€6.41M€91▼
Deferred charges and accrued income490/1€165k€142k▼
Equity and liabilities
Total equity and liabilities10/49€270.31M€253.86M▼
Equity10/15€128.48M€122.56M▼
Contributions10/11€143.28M€143.28M=
Capital10€143.27M€143.27M=
Issued capital100€143.27M€143.27M=
Outside capital11€8k€8k=
Share premium1100/10€8k€8k=
Reserves13€513k€513k=
Non-distributable reserves130/1€30k€30k=
Legal reserve130€30k€30k=
Distributable reserves133€483k€483k=
Profit (loss) carried forward14€-15.31M€-21.23M▼
Amounts payable17/49€141.83M€131.30M▼
Amounts payable after more than one year17€136.95M€128.41M▼
Financial debts170/4€136.95M€128.41M▼
Other loans174€136.95M€128.41M▼
Amounts payable within one year42/48€564k€1.03M▲
Trade debts44€564k€1.03M▲
Suppliers440/4€564k€1.03M▲
Accrued charges and deferred income492/3€4.32M€1.86M▼
Income statement
Code20232024
Operating income70/76A€11.75M€12.40M▲
Turnover70€11.43M€11.99M▲
Other operating income74€31k-
Non-recurring operating income76A€282k€413k▲
Operating charges60/66A€13.37M€13.54M▲
Services and other goods61€13.37M€13.49M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€7k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€40k
Other operating charges640/8€960€1k▲
Operating profit (loss)9901€-1.63M€-1.14M▲
Financial income75/76B€10.52M€6.61M▼
Recurring financial income75€10.52M€6.61M▼
Income from financial fixed assets750€10.52M€6.61M▼
Other financial income752/9€1k€8k▲
Financial charges65/66B€10.86M€11.37M▲
Recurring financial charges65€10.86M€11.37M▲
Debt charges650€10.85M€11.36M▲
Other financial charges652/9€8k€9k▲
Profit (loss) for the period before taxes9903€-1.96M€-5.89M▼
Income taxes67/77€25k€30k▲
Taxes670/3€25k€50k▲
Tax adjustments and reversals of tax provisions77-€21k
Profit (loss) for the period9904€-1.99M€-5.92M▼
Profit (loss) for the period to be appropriated9905€-1.99M€-5.92M▼
Appropriation of the result
Profit (loss) to be appropriated9906€-15.31M€-21.23M▼
Profit (loss) brought forward from the previous period14P€-13.32M€-15.31M▼
The notes to these accounts (40 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
30-03
State Gazette act
Registered office · Capital & shares · Statutes amendmentGeneral meeting · Capital increase · Share issue6 facts ▸
State Gazette act
Registered office · Capital & shares · Statutes amendment
General meeting · Capital increase · Share issue6 facts ▸
- General meeting, 29 januari 2026
- Capital increase, €12.000.000
- Share issue, aandelen op naam, 16155
- Capital, €174.805.932,67
- Statutes amendment
- Power of attorney, VISION HEALTHCARE
03-03
State Gazette act
Registered officeGeneral meeting · Registered-office move2 facts ▸
State Gazette act
Registered office
General meeting · Registered-office move2 facts ▸
- General meeting, 2026-02-01
- Registered-office move, Nijverheidslaan 3 te 8560 Gullegem
2025
07-10
State Gazette act
Capital & shares · Statutes amendmentGeneral meeting · Capital increase · Share issue5 facts ▸
State Gazette act
Capital & shares · Statutes amendment
General meeting · Capital increase · Share issue5 facts ▸
- General meeting, 2025-09-09
- Capital increase, €19.224.933,08
- Share issue, aandelen op naam, 28020
- Capital increase, €311.349,64
- Capital, €162.805.932,67
15-05
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
State Gazette act
Resignations & appointmentsGeneral meeting · Auditor reappointment · Permanent representative10 facts ▸
State Gazette act
Resignations & appointments
General meeting · Auditor reappointment · Permanent representative10 facts ▸
- General meeting, 2023-04-20
- Auditor reappointment, commissaris, tot de algemene vergadering der aandeelhouders die de jaarrekening per 31 december 2025 dient goed te keuren
- General meeting, 2024-04-18
- Permanent representative, outer Coppens
- General meeting, 2024-11-01
- Director resignation, OKAVANGO BV (bestuurder)
- Director discharge, OKAVANGO BV
- Director appointment, CITINI BV (bestuurder)
- Permanent representative, Deconinck Matthias
- Permanent representative, Cools Geert
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 23 days late
2023
21-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 21 days late
2022
31-12
Financial
Back to profitnet €1.43M
Net result €1.43M after one loss-making year.
31-12
Financial
Liquidity times 7current ratio 24.18
Current ratio from 3.72 to 24.18; short-term debt falls from €2.90M to €439k.
20-10
State Gazette act
Capital & shares · Statutes amendmentGeneral meeting · Capital increase · Capital5 facts ▸
State Gazette act
Capital & shares · Statutes amendment
General meeting · Capital increase · Capital5 facts ▸
- General meeting, 2022-10-04
- Capital increase, €4.500.012,29
- Capital increase, €4.500.012,29
- Capital, €143.269.649,95
- Power of attorney, VISION HEALTHCARE
30-09
State Gazette act
Resignations & appointmentsGeneral meeting · Permanent representative2 facts ▸
State Gazette act
Resignations & appointments
General meeting · Permanent representative2 facts ▸
- General meeting, 2022-05-20
- Permanent representative, Peter Opsomer
01-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Weakest financial yearnet €-14.75M ▼1454%
Net result drops to €-14.75M, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €100MEq €120.04M ▲40.6%
Equity rises from €85.36M to €120.04M.
13-12
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Director appointment7 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Director appointment7 facts ▸
- General meeting, 2021-12-01
- Director resignation, Damier NV (bestuurder)
- Director appointment, Brandracer BV (bestuurder)
- Mandate compensation, Brandracer BV
- Auditor appointment, PwC Sedrijfsrevisoren SV (commissaris)
- Board composition, bestuurder, 2021-12-01
- Board composition, bestuurder, 2021-12-01
19-07
State Gazette act
Statutes amendmentGeneral meeting · Capital increase · Share issue5 facts ▸
State Gazette act
Statutes amendment
General meeting · Capital increase · Share issue5 facts ▸
- General meeting, 2021-06-30
- Capital increase, €7.979.319,79
- Share issue, nieuwe volledig gestorte aandelen, 23654
- Capital, €134.269.625,37
- Statutes amendment
12-07
State Gazette act
Capital & sharesGeneral meeting · Capital increase · Capital5 facts ▸
State Gazette act
Capital & shares
General meeting · Capital increase · Capital5 facts ▸
- General meeting, 2021-06-30
- Capital increase, €18.989.816,18
- Capital, €126.290.305,58
- Power of attorney, VISION HEALTHCARE
- Power of attorney, Kurt Vuylsteke
16-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
15-06
State Gazette act
Capital & sharesGeneral meeting · Capital increase · Capital4 facts ▸
State Gazette act
Capital & shares
General meeting · Capital increase · Capital4 facts ▸
- General meeting, 2021-06-01
- Capital increase, €22.465.586,4
- Capital, €107.300.489,4
- Power of attorney, bestuurders
2020
31-12
Financial
Back to profitnet €1.09M
Net result €1.09M after one loss-making year.
31-12
Financial
Equity above €50MEq €85.36M ▲170%
Equity rises from €31.56M to €85.36M.
24-09
State Gazette act
Resignations & appointmentsDirector resignation1 fact ▸
State Gazette act
Resignations & appointments
Director resignation1 fact ▸
- Director resignation, The Advice Company Comm.V. (bestuurder)
16-07
State Gazette act
Resignations & appointmentsGeneral meeting · Statutes amendment · Capital36 facts ▸
State Gazette act
Resignations & appointments
General meeting · Statutes amendment · Capital36 facts ▸
- General meeting, 2020-06-18
- Statutes amendment
- Statutes amendment
- Capital, €84.834.903
- Corporate purpose, De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, voor eigen rekening of voor rekening van derden of door deelneming: I. Specifieke act…
- Director resignation, Damier (bestuurder)
- Director resignation, Okavango (bestuurder)
- Director resignation, Thierry Bogaert (bestuurder)
- Director resignation, ADC Consult (bestuurder)
- Director resignation, VAN RAPPARD Teun (bestuurder)
- Director resignation, Creafund (bestuurder)
- Director resignation, Casa Damier (bestuurder)
- +24 further facts in this act
25-06
State Gazette act
Capital & shares · Resignations & appointmentsShare issue · Capital · Power of attorney9 facts ▸
State Gazette act
Capital & shares · Resignations & appointments
Share issue · Capital · Power of attorney9 facts ▸
- Share issue, B, 6073
- Capital, €84.834.903
- Power of attorney, Matthias Deconinck
- Power of attorney, Matthieu Maselis
- Material error correction, EUR, 72750088.64
- Share class breakdown, 287896, 34964
- Dividend entitlement, dividendgerechtigd voor het volledig lopend boekjaar
- Issue price
- Subscription price allocation, EUR, 614698.0
03-06
State Gazette act
Statutes amendment · Resignations & appointmentsGeneral meeting · Statutes amendment · Capital9 facts ▸
State Gazette act
Statutes amendment · Resignations & appointments
General meeting · Statutes amendment · Capital9 facts ▸
- General meeting, 2020-05-11
- Statutes amendment
- Statutes amendment
- Capital, €84.202.205
- Corporate purpose, Het fabriceren, verdelen en verkopen van farmaceutische preparaten, voedingssupplementen, grondstoffen, cosmetische producten, zepen en reinigingsmiddelen; inri…
- Board composition, 9 members: 5 appointed on nomination of Soort A shareholders, 1 by Soort C shareholders, 1 by CreaVision Healthcare B. Maatschap, 2 by the Consortium
- Transfer restriction, Soort B shareholders may not transfer shares until 22 February 2023; Soort C shareholders may not transfer shares until 31 December 2021
- External representation, The company is validly represented by two directors, at least one of whom is a Soort A director, acting jointly
- Shareholders agreement, Shareholders' agreement dated 2 April 2019
92.2% of this act was read; anything after the cut is not in this list.Read the act at the Belgisch Staatsblad ↗
25-05
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
25-05
NBB filing
Annual accounts filed
fiscal year 2019 · consolidated
27-03
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Director appointment4 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Director appointment4 facts ▸
- General meeting, 2020-02-28
- Director resignation, Yvan Vindevogel (bestuurder)
- Director appointment, Edouard Vindevogel (bestuurder)
- Permanent representative, Herman Wielfaert
2019
11-12
State Gazette act
Resignations & appointmentsGeneral meeting · Director appointment · Permanent representative7 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director appointment · Permanent representative7 facts ▸
- General meeting, 2019-06-24
- Director appointment, Casa Damier BVBA (bestuurder)
- Permanent representative, Catherine Debal
- Director appointment, Henri Vindevogel (bestuurder)
- Director appointment, Anthony Teun Ridder van Rappard (bestuurder)
- Director appointment, ADC Consult Comm.V. (bestuurder)
- Permanent representative, Anthony De Clerck
22-07
NBB filing
Annual accounts filed
fiscal year 2018 · consolidated
18-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
09-04
State Gazette act
Capital & sharesGeneral meeting · Capital increase · Capital7 facts ▸
State Gazette act
Capital & shares
General meeting · Capital increase · Capital7 facts ▸
- General meeting, 2019-04-02
- Capital increase, €23.530.676,64
- Capital increase, €11.469.323,36
- Capital, €84.202.205
- Statutes amendment
- Approval, verslagen van de raad van bestuur en van de commissaris
- Power of attorney, Raad van bestuur
05-04
State Gazette act
MiscellaneousGeneral meeting1 fact ▸
State Gazette act
Miscellaneous
General meeting1 fact ▸
- General meeting, 2019-02-11
26-02
State Gazette act
Capital & shares · Resignations & appointmentsGeneral meeting · Auditor appointment · Capital increase19 facts ▸
State Gazette act
Capital & shares · Resignations & appointments
General meeting · Auditor appointment · Capital increase19 facts ▸
- General meeting, 2019-02-14
- Auditor appointment, PwC Bedrijfsrevisoren (commissaris)
- Capital increase, €7.450.579,69
- Capital increase, €4.834.020,31
- Capital, €49.220.205
- Statutes amendment
- Share transfer, Georges Van Nevel → Stichting Administratiekantoor Vision Healthcare
- Share transfer, Alain Duperray → Stichting Administratiekantoor Vision Healthcare
- Share transfer, Koen Van Elverdinghe → Stichting Administratiekantoor Vision Healthcare
- Share transfer, Kristen Schrijvers → Stichting Administratiekantoor Vision Healthcare
- Director appointment, CREAFUND (bestuurder)
- Permanent representative, H&H CAPITAL MANAGEMENT
- +7 further facts in this act
18-02
State Gazette act
Capital & sharesGeneral meeting · Capital increase · Capital6 facts ▸
State Gazette act
Capital & shares
General meeting · Capital increase · Capital6 facts ▸
- General meeting, 2019-02-13
- Capital increase, €2.856.499
- Capital increase, €2.143.501
- Capital, €36.935.605
- Statutes amendment
- Power of attorney, Raad van bestuur
2018
16-10
State Gazette act
Capital & sharesGeneral meeting · Auditor appointment · Capital increase9 facts ▸
State Gazette act
Capital & shares
General meeting · Auditor appointment · Capital increase9 facts ▸
- General meeting, 2018-10-11
- Auditor appointment, Ilse De Baets (commissaris)
- Capital increase, €246.500
- Capital increase, €168.805
- Capital, €31.935.605
- Share transfer, Johan De Loor → Stichting Administratiekantoor Vision Healthcare
- Share transfer, Thomas Wallace → Stichting Administratiekantoor Vision Healthcare
- Share transfer, Philip Prosser → Stichting Administratiekantoor Vision Healthcare
- Power of attorney, Raad van bestuur Vision Healthcare
19-06
State Gazette act
MiscellaneousGeneral meeting · Approval · Auditor appointment4 facts ▸
State Gazette act
Miscellaneous
General meeting · Approval · Auditor appointment4 facts ▸
- General meeting, 2018-05-29
- Approval
- Auditor appointment, BV ovve CVBA PwC Bedrijfsrevisoren (commissaris)
- Permanent representative, Ilse De Baets
30-03
State Gazette act
Capital & shares · Resignations & appointmentsGeneral meeting · Capital increase · Capital18 facts ▸
State Gazette act
Capital & shares · Resignations & appointments
General meeting · Capital increase · Capital18 facts ▸
- General meeting, 2018-02-22
- Capital increase, €25.345.300
- Capital increase, €4.925.000
- Capital, €31.520.300
- Director resignation, VISION HEALTHCARE
- Director appointment, DAMIER (bestuurder)
- Permanent representative, VINDEVOGEL Yvan Valère Marguerite
- Director appointment, OKAVANGO (bestuurder)
- Permanent representative, LEMAIRE Bernard Jean Yvon Marie Hubert
- Director appointment, VINDEVOGEL Yvan Valère Marguerite (bestuurder)
- Director appointment, THIERRY BOGAERT (bestuurder)
- Permanent representative, LEMAIRE Bernard Jean Yvon Marie Hubert
- +6 further facts in this act
2017
14-12
State Gazette act
IncorporationIncorporation · Founding capital · First fiscal year12 facts ▸
State Gazette act
Incorporation
Incorporation · Founding capital · First fiscal year12 facts ▸
- Incorporation, 2017-12-11
- Founding capital, €1.250.000
- First fiscal year, 2017-12-11/2018-12-31
- Corporate purpose, De vennootschap heeft tot doel, zowel in België als in het buitenland, voor eigen rekening of voor rekening van derden of door deelneming: I. Specifieke activit…
- Director appointment, DAMIER (bestuurder)
- Director appointment, OKAVANGO (bestuurder)
- Permanent representative, VINDEVOGEL Yvan Valère Marguerite
- Permanent representative, LEMAIRE Bernard Jean Yvon Marie Hubert
- Director appointment, DAMIER (voorzitter van de raad van bestuur)
- Director appointment, DAMIER (gedelegeerd bestuurder)
- Founder, DAMIER
- Founder, LEMAIRE Bernard Jean Yvon Marie Hubert
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
19 directors, last change in 2024
CITINI BV
CurrentDirector · since 01-11-2024 · Legal entity · perm. rep.: Deconinck Matthias
BRANDRACER
CurrentDirector · since 01-12-2021 · Private limited company
Damier
Not recently confirmedDirector · since 18-06-2020 · Legal entity · perm. rep.: VINDEVOGEL Yvan Valère Marguerite
OKAVANGO
Not recently confirmedDirector · since 18-06-2020 · Private limited company · perm. rep.: LEMAIRE Bernard Jean Yvon Marie Hubert
THE ADVICE COMPANY
Not recently confirmedDirector · since 18-06-2020 · Limited partnership · perm. rep.: DOBBELAERE Bart
Anthony Teun Ridder van Rappard
Not recently confirmedDirector · since 05-06-2019
+ 3 not shown in this overview
01-11-2024
CITINI BV: Appointed as Director
01-11-2024
OKAVANGO BV: Resigned as Director
01-12-2021
BRANDRACER: Appointed as Director
01-12-2021
DAMIER NV: Resigned as Director
01-09-2020
The Advice Company Comm.V.: Resigned as Director
18-06-2020
Damier: Resigned as Director
18-06-2020
Damier: Appointed as Director
18-06-2020
OKAVANGO: Resigned as Director
18-06-2020
OKAVANGO: Appointed as Director
18-06-2020
THE ADVICE COMPANY: Appointed as Director
18-06-2020
ADC CONSULT: Resigned as Director
18-06-2020
CASA DAMIER: Resigned as Director
18-06-2020
CREAFUND: Resigned as Director
18-06-2020
Edouard Vindevogel: Resigned as Director
18-06-2020
VAN RAPPARD Teun: Resigned as Director
18-06-2020
VINDEVOGEL Henri: Resigned as Director
01-01-2020
Edouard Vindevogel: Appointed as Director
01-01-2020
Yvan Vindevogel: Resigned as Director
05-06-2019
Anthony Teun Ridder van Rappard: Appointed as Director
05-06-2019
ADC CONSULT: Appointed as Director
05-06-2019
CASA DAMIER: Appointed as Director
05-06-2019
VINDEVOGEL Henri: Appointed as Director
14-02-2019
CREAFUND: Appointed as Director
22-02-2018
Damier: Appointed as Voorzitter van de raad van bestuur
+ 9 not shown in this overview
Not every act has been read: a resignation may be missing here
1 act was read only in part. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Wevelgem · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Nijverheidslaan 38560 WevelgemGround area
1.3 ha
Building footprint
8,072 m²
Volume, LiDAR
37,591 m³
Parcel 34012A0428/02P002, Flanders · tallest building 9.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Vision Healthcare NV
since 20182.275.095.111
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34012A0428/02P002 | Flanders | 1.3 ha | 1 · 8,072 m² | 9.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Statutory auditor
5 auditors| BV PwC BedrijfsrevisorenCurrent Statutory auditor · represented by outer Coppens | 20-04-2023 → present |
Show 4 earlier auditors
| BV ovve CVBA PwC Bedrijfsrevisoren Statutory auditor · represented by Ilse De Baets succeeded by PwC Sedrijfsrevisoren SV in 2021 | 29-05-2018 → 21-04-2021 |
| Ilse de Baets Statutory auditor succeeded by PwC Sedrijfsrevisoren SV in 2021 | 11-10-2018 → 21-04-2021 |
| Pwc Bedrijfsrevisoren Statutory auditor succeeded by PwC Sedrijfsrevisoren SV in 2021 | 14-02-2019 → 21-04-2021 |
| PwC Sedrijfsrevisoren SV Statutory auditor succeeded by BV PwC Bedrijfsrevisoren in 2023 | 21-04-2021 → 20-04-2023 |
Structure & network
Connections & network
7 connected companiesNetwork connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Show 3 more network connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Ownership & control
8 partiesControl over this companysits on this company's board8
5 subsidiaries · 1 location
2 subsidiaries · 1 location
2 subsidiaries · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
+2 more
in the list below
controls
VISION HEALTHCAREBE 0685.849.188
Group per the LEI register
1 subsidiary, 1 abroadSubsidiary:VISION HEALTHCARE B.V.
Capital and shareholders
Capital increase of 12,000,000 EUR · 16,155 new shares
Capital increase of 19,224,933.08 EUR · 28,389 new shares
Capital increase of 311,349.64 EUR · 460 new shares
Capital increase of 4,500,012.29 EUR · 6,472 new shares
Capital increase of 4,500,012.29 EUR · 6,472 new shares
Capital increase of 7,979,319.79 EUR · 23,654 new shares
Capital increase of 18,989,816.18 EUR · 56,294 new shares
Capital increase of 22,465,586.40 EUR · 66,598 new shares
Capital increase of 23,530,676.64 EUR
Capital increase of 11,469,323.36 EUR
Capital increase of 7,450,579.69 EUR
Capital increase of 4,834,020.31 EUR
Transfer of 2,094 shares from Georges Van Nevel to Stichting Administratiekantoor Vision Healthcare
Transfer of 1,745 shares from Alain Duperray to Stichting Administratiekantoor Vision Healthcare
Transfer of 1,745 shares from Koen Van Elverdinghe to Stichting Administratiekantoor Vision Healthcare
Transfer of 1,745 shares from Kristen Schrijvers to Stichting Administratiekantoor Vision Healthcare
Show 4 more events
Capital increase of 2,856,499 EUR
Capital increase of 2,143,501 EUR
Capital increase of 246,500 EUR · 2,465 new shares
Capital increase of 168,805 EUR · no new shares
Transfer of 1,000 shares from Johan De Loor to Stichting Administratiekantoor Vision Healthcare
Transfer of 1,816 shares from Thomas Wallace to Stichting Administratiekantoor Vision Healthcare
Transfer of 649 shares from Philip Prosser to Stichting Administratiekantoor Vision Healthcare
Capital increase of 25,345,300 EUR · 253,453 new shares
Capital increase of 4,925,000 EUR · 49,250 new shares
Founding capital 1,250,000 EUR
Recognitions · licences · registrations
Legal Entity Identifier
894500VK09R41RI8I706
Similar companies · same sector, comparable size
Ipsen
BE 0422.650.477
Brussel · Eq €119.88M
Pfizer
BE 0401.994.823
Elsene · Eq €155.73M
BAXTER
BE 0403.093.693
Lessines · Eq €83.81M
PHYSIOL
BE 0428.242.033
Liège · Eq €78.44M
ODYSSEA PHARMA
BE 0892.121.272
Grâce-Hollogne · Eq €76.39M
Of 149 companies in sector 21201 we hold annual accounts for 116. 33 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded12-12-2017
Fiscal year end31-12
Activities, NACEBEL
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
64200Holdings
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.